当前位置:首页 / IL17A基因rs2275913位点多态性与2型糖尿病及其微血管并发症的关联研究
| 更新时间:2026-11-20
|
IL17A基因rs2275913位点多态性与2型糖尿病及其微血管并发症的关联研究
Study on the association of IL17A gene rs2275913 polymorphism with type 2 diabetes mellitus and its microvascular complications

内科 页码:539-545

作者机构:1 汝州市第一人民医院内分泌科,河南省汝州市 467500;2 汝州市中医院检验科,河南省汝州市 467500

DOI:10.16121/j.cnki.cn45-1347/r.2026.05.05

  • 中文简介
  • 英文简介
  • 参考文献

目的 探讨IL17A基因rs2275913位点多态性与2型糖尿病(T2DM)及其微血管并发症的关联。方法 选取汝州市第一人民医院2022年1月至2023年12月收治的296例T2DM患者作为研究组,另按2∶1比例选取同期健康体检者148例作为对照组。采用聚合酶链反应-限制性片段长度多态性技术检测IL17A基因rs2275913位点多态性,并采用Hardy-Weinberg遗传平衡检验评价样本代表性。(1)T2DM遗传易感性分析:比较病例组与对照组基因型及等位基因分布,明确该位点多态性与T2DM患病风险的关联。(2)微血管并发症影响因素分析:将296例T2DM患者按是否并发微血管并发症分为并发组(121例)和未并发组(175例),比较两组临床资料及基因型分布,采用多因素logistic回归分析微血管并发症的独立相关因素。结果 研究组与对照组IL17A基因rs2275913位点基因型分布均符合Hardy-Weinberg遗传平衡定律(均P>0.05)。(1)T2DM遗传易感性分析显示:病例组GG基因型频率低于对照组(37.84%比50.68%,校正后P<0.0167),A等位基因频率高于对照组(40.71%比30.41%,P=0.003)。(2)微血管并发症影响因素分析显示:并发组与未并发组在高脂血症病史、空腹血糖、HbA1c、总胆固醇、甘油三酯及IL17A基因型分布方面差异均具有统计学意义(均P<0.05);多因素logistic回归分析显示,IL17A基因rs2275913位点AA基因型(OR=1.842,95%CI:1.142~2.972)、高脂血症病史(OR=2.366,95%CI:1.316~4.251)、空腹血糖(OR=1.631,95%CI:1.072~2.480)及HbA1c(OR=1.508,95%CI:1.140~1.996)均与T2DM患者微血管并发症独立相关(均P<0.05)。结论 IL17A基因rs2275913位点多态性与T2DM及其微血管并发症均存在统计学关联,AA基因型可能增加T2DM患者微血管并发症的易感性。高脂血症病史及空腹血糖、HbA1c水平亦为微血管并发症独立相关因素。

Objective To investigate the association between IL17A gene rs2275913 polymorphism and type 2 diabetes mellitus (T2DM) and its microvascular complications. Methods A total of 296 patients with T2DM admitted to the First People's Hospital of Ruzhou from January 2022 to December 2023 were enrolled as the study group, and 148 healthy controls were selected at a 2:1 ratio during the same period. Polymerase chain reaction-restriction fragment length polymorphism was used to detect the IL17A gene rs2275913 polymorphism, and the Hardy-Weinberg equilibrium test was applied to evaluate sample representativeness. (1) Genetic susceptibility analysis of T2DM: Genotype and allele distributions were compared between the study group and the control group to determine the association between this polymorphism and T2DM risk. (2) Analysis of influencing factors for microvascular complications: The 296 T2DM patients were divided into a complication group (n=121) and a non-complication group (n=175) based on the presence or absence of microvascular complications. Clinical data and genotype distributions were compared between the two groups, and multivariate logistic regression analysis was performed to identify independent factors associated with microvascular complications. Results The genotype distributions of the IL17A gene rs2275913 polymorphism in both the study group and the control group were in Hardy-Weinberg equilibrium (both P>0.05). (1) Genetic susceptibility analysis showed that the frequency of the GG genotype in the case group was lower than that in the control group (37.84% vs. 50.68%, adjusted P<0.0167), and the frequency of the A allele was higher than that in the control group (40.71% vs. 30.41%, P=0.003). (2) Analysis of influencing factors for microvascular complications showed statistically significant differences between the complication group and the non-complication group in terms of history of hyperlipidemia, fasting blood glucose, HbA1c, total cholesterol, triglycerides, and IL17A genotype distribution (all P<0.05). Multivariate logistic regression analysis revealed that the AA genotype of IL17A gene rs2275913 (OR=1.842, 95% CI: 1.142-2.972), history of hyperlipidemia (OR=2.366, 95% CI: 1.316-4.251), fasting blood glucose (OR=1.631, 95% CI: 1.072-2.480), and HbA1c (OR=1.508, 95% CI: 1.140-1.996) were independently associated with microvascular complications in T2DM patients (all P<0.05). Conclusion The IL17A gene rs2275913 polymorphism is statistically associated with T2DM and its microvascular complications. Carrying the AA genotype may increase susceptibility to microvascular complications in T2DM patients. History of hyperlipidemia and elevated levels of fasting blood glucose and HbA1c are also independently associated with microvascular complications.

    无

5

浏览量

0

下载量

0

CSCD

工具集